Clinical Trial Update: Pyroxamide in Treating Patients With Advanced Cancer [Phase 1]

View source ↗

Summary

Clinical trial update for Pyroxamide in advanced cancer: a Phase 1 study sponsored by Memorial Sloan Karger Cancer Center has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma and Plasma Cell Neoplasms
• Myelodysplastic Syndromes
• Myeloproliferative Disorders
• Precancerous Conditions
• Small Intestine Cancer
• Solid Tumors

Drugs mentioned

• Pyroxamide (pyroxamide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Chronic Myeloproliferative Disorders, Leukemia | Phase 1 | Status: COMPLETED